Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals the need for new treatment strategies in patients with slowly progressive fibrillary glomerulonephritis.
Fibrillary glomerulonephritis is a heterogenous disease, and a significant number of patients present with a slowly progressive disease, warranting long-term treatment. New treatment strategies are necessary.
No takes yet. Share an insight, caveat, or question.
Dovc et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: